• Home
  • Stories
  • Discover
  • Explore
  • Events
  • Leaderboard
For organizationsSign inSign up
  • Home
  • Stories
  • Discover
  • Explore
  • Events
  • Leaderboard
A Cure in Sight
  • Programs
  • Long reads
  • About
HomeStoriesDiscoverEventsSign up
A Cure in Sight
ReportPDF2022 – Annual Report2022
A Cure in SightNC · Health

2022 – Annual Report

Report · 2022

13 pages
Open the PDF ↗
More long reads
  • acureinsight.orgFDA Launches Rare Disease Framework Initiative: What It Could Mean for Our Community Highlights3 min read · Oct 18
  • acureinsight.orgCan a Biopsy Help Predict Who Responds to TIL Therapy?3 min read · Oct 14
  • acureinsight.orgWhy Uveal Melanoma Is Different, and What That Means for Treatment2 min read · Oct 9
  • acureinsight.orgA Cure In Sight and UT Southwestern Bring the Ocular Melanoma Community Together at Eye Believe in Dallas4 min read · Oct 8
  • acureinsight.orgNew Clues on Why TIL Immunotherapy Works for Some Melanoma Patients2 min read · Aug 20
  • acureinsight.orgAdvances in Ocular Oncology Offer New Hope for Patients and Families2 min read · Aug 16
  • acureinsight.orgNew Targeted Therapy Shows Early Promise for Metastatic Uveal Melanoma2 min read · Aug 12
  • acureinsight.orgNew Immunotherapy Research May Help Strengthen Future Cancer Treatments2 min read · Aug 8
  • acureinsight.orgNew Research May Improve How Doctors Predict Metastasis Risk in Uveal Melanoma3 min read · Aug 3
  • acureinsight.orgA Cure In Sight Earns Charity Navigator's 2026 Four-Star Rating2 min read · Jul 28
  • acureinsight.orgHope Beyond a Rare Diagnosis: One Father's Uveal Melanoma Journey Shows the Power of Clinical Trials2 min read · Jul 22
  • acureinsight.orgNew Blood Test Monitoring Tool Offers Additional Insight for Uveal Melanoma Care2 min read · Jul 18